{"id":"https://openalex.org/W7214309762","doi":"https://doi.org/10.64898/2026.09.24.754095","title":"Disrupting aberrant EGFR catalytic trimers reverses T790M gefitinib resistance","display_name":"Disrupting aberrant EGFR catalytic trimers reverses T790M gefitinib resistance","publication_year":2026,"publication_date":"2026-09-25","ids":{"openalex":"https://openalex.org/W7214309762","doi":"https://doi.org/10.64898/2026.09.24.754095"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.24.754095","doi":"https://doi.org/10.64898/2026.09.24.754095","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.24.754095","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/25/2026.09.24.754095.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/25/2026.09.24.754095.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041530320","display_name":"Selene K. Roberts","orcid":"https://orcid.org/0000-0002-3732-0556","observed_orcids":["https://orcid.org/0000-0002-3732-0556"]},"institutions":[{"id":"https://openalex.org/I1286704778","display_name":"Rutherford Appleton Laboratory","ror":"https://ror.org/03gq8fr08","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I162524378","display_name":"Science and Technology Facilities Council","ror":"https://ror.org/057g20z61","country_code":"GB","type":"government","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I4391767682","display_name":"Central Laser Facility","ror":"https://ror.org/05efe5r97","country_code":"GB","type":"facility","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105","https://openalex.org/I4391767682"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Selene K. Roberts","raw_affiliation_strings":["Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK","institution_ids":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4391767682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041159725","display_name":"Ioannis Galdadas","orcid":"https://orcid.org/0000-0003-2136-9723","observed_orcids":["https://orcid.org/0000-0003-2136-9723"]},"institutions":[{"id":"https://openalex.org/I114457229","display_name":"University of Geneva","ror":"https://ror.org/01swzsf04","country_code":"CH","type":"education","lineage":["https://openalex.org/I114457229"]},{"id":"https://openalex.org/I30771326","display_name":"Italian Institute of Technology","ror":"https://ror.org/042t93s57","country_code":"IT","type":"facility","lineage":["https://openalex.org/I30771326"]}],"countries":["CH","IT"],"is_corresponding":false,"raw_author_name":"Ioannis Galdadas","raw_affiliation_strings":["Atomistic Simulations, Italian Institute of Technology, Genova, IT","ISPSO, University of Geneva, Geneva, CH","School of Pharmaceutical Sciences, University of Geneva, Geneva, CH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Atomistic Simulations, Italian Institute of Technology, Genova, IT","institution_ids":["https://openalex.org/I30771326"]},{"raw_affiliation_string":"ISPSO, University of Geneva, Geneva, CH","institution_ids":["https://openalex.org/I114457229"]},{"raw_affiliation_string":"School of Pharmaceutical Sciences, University of Geneva, Geneva, CH","institution_ids":["https://openalex.org/I114457229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008779308","display_name":"Nicola Piasentin","orcid":"https://orcid.org/0000-0003-2760-4640","observed_orcids":["https://orcid.org/0000-0003-2760-4640"]},"institutions":[{"id":"https://openalex.org/I114457229","display_name":"University of Geneva","ror":"https://ror.org/01swzsf04","country_code":"CH","type":"education","lineage":["https://openalex.org/I114457229"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Nicola Piasentin","raw_affiliation_strings":["ISPSO, University of Geneva, Geneva, CH","School of Pharmaceutical Sciences, University of Geneva, Geneva, CH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ISPSO, University of Geneva, Geneva, CH","institution_ids":["https://openalex.org/I114457229"]},{"raw_affiliation_string":"School of Pharmaceutical Sciences, University of Geneva, Geneva, CH","institution_ids":["https://openalex.org/I114457229"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076746475","display_name":"Sarah R. Needham","orcid":"https://orcid.org/0000-0002-3311-1036","observed_orcids":["https://orcid.org/0000-0002-3311-1036"]},"institutions":[{"id":"https://openalex.org/I1286704778","display_name":"Rutherford Appleton Laboratory","ror":"https://ror.org/03gq8fr08","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I162524378","display_name":"Science and Technology Facilities Council","ror":"https://ror.org/057g20z61","country_code":"GB","type":"government","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I4391767682","display_name":"Central Laser Facility","ror":"https://ror.org/05efe5r97","country_code":"GB","type":"facility","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105","https://openalex.org/I4391767682"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah R. Needham","raw_affiliation_strings":["Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK","institution_ids":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4391767682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002447216","display_name":"Benjamin Michael Davis","orcid":"https://orcid.org/0000-0002-9883-7356","observed_orcids":["https://orcid.org/0000-0002-9883-7356","https://orcid.org/0000-0001-6121-1635"]},"institutions":[{"id":"https://openalex.org/I1286704778","display_name":"Rutherford Appleton Laboratory","ror":"https://ror.org/03gq8fr08","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I162524378","display_name":"Science and Technology Facilities Council","ror":"https://ror.org/057g20z61","country_code":"GB","type":"government","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I4391767682","display_name":"Central Laser Facility","ror":"https://ror.org/05efe5r97","country_code":"GB","type":"facility","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105","https://openalex.org/I4391767682"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Benjamin M. Davis","raw_affiliation_strings":["Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK","institution_ids":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4391767682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024529426","display_name":"Laura C. Zanetti-Domingues","orcid":"https://orcid.org/0000-0003-0514-3185","observed_orcids":["https://orcid.org/0000-0003-0514-3185"]},"institutions":[{"id":"https://openalex.org/I1286704778","display_name":"Rutherford Appleton Laboratory","ror":"https://ror.org/03gq8fr08","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I162524378","display_name":"Science and Technology Facilities Council","ror":"https://ror.org/057g20z61","country_code":"GB","type":"government","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I4391767682","display_name":"Central Laser Facility","ror":"https://ror.org/05efe5r97","country_code":"GB","type":"facility","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105","https://openalex.org/I4391767682"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Laura C. Zanetti-Domingues","raw_affiliation_strings":["Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK","institution_ids":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4391767682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055792424","display_name":"Rico C.H. Man","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rico C. H. Man","raw_affiliation_strings":["Imaging Therapies and Cancer Group, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging Therapies and Cancer Group, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078450976","display_name":"David T. Clarke","orcid":"https://orcid.org/0000-0002-8776-1341","observed_orcids":["https://orcid.org/0000-0002-8776-1341"]},"institutions":[{"id":"https://openalex.org/I1286704778","display_name":"Rutherford Appleton Laboratory","ror":"https://ror.org/03gq8fr08","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I162524378","display_name":"Science and Technology Facilities Council","ror":"https://ror.org/057g20z61","country_code":"GB","type":"government","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I4391767682","display_name":"Central Laser Facility","ror":"https://ror.org/05efe5r97","country_code":"GB","type":"facility","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105","https://openalex.org/I4391767682"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"David T. Clarke","raw_affiliation_strings":["Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK","institution_ids":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4391767682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038047143","display_name":"Andrew H. A. Clayton","orcid":"https://orcid.org/0000-0002-6182-3049","observed_orcids":["https://orcid.org/0000-0002-6182-3049"]},"institutions":[{"id":"https://openalex.org/I57093077","display_name":"Swinburne University of Technology","ror":"https://ror.org/031rekg67","country_code":"AU","type":"education","lineage":["https://openalex.org/I57093077"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew H. A. Clayton","raw_affiliation_strings":["Optical Sciences Centre, School of Science, Computing and Emerging Technologies, Swinburne University of Technology, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Optical Sciences Centre, School of Science, Computing and Emerging Technologies, Swinburne University of Technology, Melbourne, Australia","institution_ids":["https://openalex.org/I57093077"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056725171","display_name":"Daniel J. Rolfe","orcid":"https://orcid.org/0000-0002-8394-8395","observed_orcids":["https://orcid.org/0000-0002-8394-8395"]},"institutions":[{"id":"https://openalex.org/I1286704778","display_name":"Rutherford Appleton Laboratory","ror":"https://ror.org/03gq8fr08","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I162524378","display_name":"Science and Technology Facilities Council","ror":"https://ror.org/057g20z61","country_code":"GB","type":"government","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I4391767682","display_name":"Central Laser Facility","ror":"https://ror.org/05efe5r97","country_code":"GB","type":"facility","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105","https://openalex.org/I4391767682"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Daniel J. Rolfe","raw_affiliation_strings":["Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK","institution_ids":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4391767682"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078574037","display_name":"Gilbert O. Fruhwirth","orcid":"https://orcid.org/0000-0002-1438-2674","observed_orcids":["https://orcid.org/0000-0002-1438-2674"]},"institutions":[{"id":"https://openalex.org/I183935753","display_name":"King's College London","ror":"https://ror.org/0220mzb33","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I183935753"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Gilbert O. Fruhwirth","raw_affiliation_strings":["Imaging Therapies and Cancer Group, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging Therapies and Cancer Group, Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King\u2019s College London, London, UK","institution_ids":["https://openalex.org/I183935753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023053470","display_name":"Francesco Luigi Gervasio","orcid":"https://orcid.org/0000-0003-4831-5039","observed_orcids":["https://orcid.org/0000-0003-4831-5039"]},"institutions":[{"id":"https://openalex.org/I114457229","display_name":"University of Geneva","ror":"https://ror.org/01swzsf04","country_code":"CH","type":"education","lineage":["https://openalex.org/I114457229"]},{"id":"https://openalex.org/I30771326","display_name":"Italian Institute of Technology","ror":"https://ror.org/042t93s57","country_code":"IT","type":"facility","lineage":["https://openalex.org/I30771326"]}],"countries":["CH","IT"],"is_corresponding":false,"raw_author_name":"Francesco L. Gervasio","raw_affiliation_strings":["Atomistic Simulations, Italian Institute of Technology, Genova, IT","ISPSO, University of Geneva, Geneva, CH","School of Pharmaceutical Sciences, University of Geneva, Geneva, CH"],"raw_orcid":"https://orcid.org/0000-0003-4831-5039","affiliations":[{"raw_affiliation_string":"Atomistic Simulations, Italian Institute of Technology, Genova, IT","institution_ids":["https://openalex.org/I30771326"]},{"raw_affiliation_string":"ISPSO, University of Geneva, Geneva, CH","institution_ids":["https://openalex.org/I114457229"]},{"raw_affiliation_string":"School of Pharmaceutical Sciences, University of Geneva, Geneva, CH","institution_ids":["https://openalex.org/I114457229"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105409307","display_name":"Marisa L. Martin-Fernandez","orcid":"https://orcid.org/0000-0001-5496-6300","observed_orcids":["https://orcid.org/0000-0001-5496-6300"]},"institutions":[{"id":"https://openalex.org/I1286704778","display_name":"Rutherford Appleton Laboratory","ror":"https://ror.org/03gq8fr08","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I162524378","display_name":"Science and Technology Facilities Council","ror":"https://ror.org/057g20z61","country_code":"GB","type":"government","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105"]},{"id":"https://openalex.org/I4391767682","display_name":"Central Laser Facility","ror":"https://ror.org/05efe5r97","country_code":"GB","type":"facility","lineage":["https://openalex.org/I162524378","https://openalex.org/I4210087105","https://openalex.org/I4391767682"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Marisa L. Martin-Fernandez","raw_affiliation_strings":["Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK"],"raw_orcid":"https://orcid.org/0000-0001-5496-6300","affiliations":[{"raw_affiliation_string":"Central Laser Facility, UKRI-STFC Rutherford Appleton Laboratory, Didcot, Oxfordshire, UK","institution_ids":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4391767682"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5105409307"],"corresponding_institution_ids":["https://openalex.org/I1286704778","https://openalex.org/I162524378","https://openalex.org/I4391767682"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.9430000185966492},{"id":"https://openalex.org/keywords/egfr-t790m-mutation","display_name":"T790M mutation","score":0.9369999766349792},{"id":"https://openalex.org/keywords/gefitinib-resistance","display_name":"gefitinib resistance","score":0.996999979019165},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8330000042915344},{"id":"https://openalex.org/keywords/receptor-oligomerization","display_name":"receptor oligomerization","score":0.8069999814033508},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9169999957084656},{"id":"https://openalex.org/keywords/acquired-resistance","display_name":"acquired resistance","score":0.5529999732971191},{"id":"https://openalex.org/keywords/protein-protein-interfaces","display_name":"protein-protein interfaces","score":0.7319999933242798},{"id":"https://openalex.org/keywords/downstream-signaling","display_name":"downstream signaling","score":0.5609999895095825},{"id":"https://openalex.org/keywords/reversal-of-drug-resistance","display_name":"drug resistance reversal","score":0.43299999833106995}],"concepts":[{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.8238000273704529},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6593000292778015},{"id":"https://openalex.org/C2777930144","wikidata":"https://www.wikidata.org/wiki/Q25100112","display_name":"T790M","level":5,"score":0.6237999796867371},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5910999774932861},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.578499972820282},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.5493999719619751},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.5418000221252441},{"id":"https://openalex.org/C16318435","wikidata":"https://www.wikidata.org/wiki/Q149299","display_name":"Mutagenesis","level":4,"score":0.42559999227523804},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4058000147342682},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.4009000062942505},{"id":"https://openalex.org/C2776165026","wikidata":"https://www.wikidata.org/wiki/Q188017","display_name":"Tyrosine","level":2,"score":0.38449999690055847},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3749000132083893},{"id":"https://openalex.org/C2779546866","wikidata":"https://www.wikidata.org/wiki/Q531306","display_name":"Dimer","level":2,"score":0.3596000075340271},{"id":"https://openalex.org/C115456853","wikidata":"https://www.wikidata.org/wiki/Q17917132","display_name":"ERBB3","level":4,"score":0.3508000075817108},{"id":"https://openalex.org/C2780642029","wikidata":"https://www.wikidata.org/wiki/Q726004","display_name":"Oligomer","level":2,"score":0.33320000767707825},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.32499998807907104},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.30480000376701355},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.2971000075340271},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.29499998688697815},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.2906999886035919},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.289000004529953},{"id":"https://openalex.org/C207886595","wikidata":"https://www.wikidata.org/wiki/Q1456138","display_name":"Pathological","level":2,"score":0.28189998865127563},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.2782000005245209},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.26840001344680786},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2653999924659729},{"id":"https://openalex.org/C2993359049","wikidata":"https://www.wikidata.org/wiki/Q7575016","display_name":"Catalytic efficiency","level":3,"score":0.26489999890327454},{"id":"https://openalex.org/C176944494","wikidata":"https://www.wikidata.org/wiki/Q1415380","display_name":"Point mutation","level":4,"score":0.2524000108242035},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.2513999938964844}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.24.754095","doi":"https://doi.org/10.64898/2026.09.24.754095","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.24.754095","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/25/2026.09.24.754095.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.24.754095","doi":"https://doi.org/10.64898/2026.09.24.754095","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.24.754095","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/25/2026.09.24.754095.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6849658127","display_name":null,"funder_award_id":"ST/Y004183/1","funder_id":"https://openalex.org/F4320334632","funder_display_name":"Science and Technology Facilities Council"}],"funders":[{"id":"https://openalex.org/F4320334632","display_name":"Science and Technology Facilities Council","ror":"https://ror.org/057g20z61"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214309762.pdf","grobid_xml":"https://content.openalex.org/works/W7214309762.grobid-xml"},"referenced_works_count":63,"referenced_works":["https://openalex.org/W1031578623","https://openalex.org/W1546552389","https://openalex.org/W1650797637","https://openalex.org/W1966797647","https://openalex.org/W1968324646","https://openalex.org/W1973821009","https://openalex.org/W1978518304","https://openalex.org/W1980692621","https://openalex.org/W1986412478","https://openalex.org/W1993314049","https://openalex.org/W2002937040","https://openalex.org/W2003984225","https://openalex.org/W2010030578","https://openalex.org/W2017847830","https://openalex.org/W2025018535","https://openalex.org/W2035495099","https://openalex.org/W2043696829","https://openalex.org/W2047441570","https://openalex.org/W2048538776","https://openalex.org/W2059715478","https://openalex.org/W2069262457","https://openalex.org/W2082073804","https://openalex.org/W2088388211","https://openalex.org/W2095201384","https://openalex.org/W2099203391","https://openalex.org/W2100303404","https://openalex.org/W2100794900","https://openalex.org/W2106402455","https://openalex.org/W2107972068","https://openalex.org/W2111973486","https://openalex.org/W2117275311","https://openalex.org/W2126389097","https://openalex.org/W2143600397","https://openalex.org/W2161821474","https://openalex.org/W2162424885","https://openalex.org/W2166567143","https://openalex.org/W2167270950","https://openalex.org/W2167279371","https://openalex.org/W2276726461","https://openalex.org/W2325657998","https://openalex.org/W2327880765","https://openalex.org/W2543947893","https://openalex.org/W2623172571","https://openalex.org/W2753128050","https://openalex.org/W2769423727","https://openalex.org/W2898032821","https://openalex.org/W3012052929","https://openalex.org/W3092965608","https://openalex.org/W3135382382","https://openalex.org/W3199928453","https://openalex.org/W4211196614","https://openalex.org/W4286587504","https://openalex.org/W4313545200","https://openalex.org/W4387157421","https://openalex.org/W4392956098","https://openalex.org/W4405035146","https://openalex.org/W4408408842","https://openalex.org/W4409640798","https://openalex.org/W4411395760","https://openalex.org/W4414086936","https://openalex.org/W4417091480","https://openalex.org/W4417231484","https://openalex.org/W7116060564"],"related_works":["https://openalex.org/W2169816570","https://openalex.org/W4417091480","https://openalex.org/W2079778947","https://openalex.org/W2900712986","https://openalex.org/W1967249248","https://openalex.org/W2007528734","https://openalex.org/W2167270950","https://openalex.org/W2951280350","https://openalex.org/W2792821195","https://openalex.org/W2247029248"],"abstract_inverted_index":{"ABSTRACT":[0],"Epidermal":[1],"growth":[2],"factor":[3],"receptor":[4],"(EGFR)":[5],"mutations":[6],"drive":[7],"up":[8],"to":[9,144],"50%":[10],"of":[11,30,129],"non-small-cell":[12],"lung":[13],"cancers":[14],"(NSCLC).":[15],"Although":[16],"tyrosine":[17],"kinase":[18],"inhibitors":[19],"(TKIs)":[20],"like":[21,96],"gefitinib":[22,121],"initially":[23],"offer":[24],"substantial":[25],"clinical":[26],"benefit,":[27],"the":[28,51,69,89],"emergence":[29],"acquired,":[31],"on-target":[32],"resistance":[33,122],"inevitably":[34],"limits":[35],"long-term":[36],"remission.":[37],"Beyond":[38],"structural":[39,141],"changes":[40],"that":[41,59,148,167],"alter":[42],"ATP-pocket":[43],"affinity,":[44],"EGFR":[45],"oligomerization":[46],"drives":[47],"this":[48],"resistance,":[49,157],"though":[50],"underlying":[52],"mechanisms":[53],"remain":[54,92],"unclear.":[55],"Here":[56],"we":[57],"show":[58],"progressive,":[60],"TKI-resistant":[61],"secondary":[62],"and":[63,119,158],"tertiary":[64],"EGFR-mutant":[65],"variants":[66,84],"assemble":[67,85],"on":[68],"cell":[70],"surface":[71],"into":[72,86,107,131],"higher-order,":[73],"ligand-free":[74],"oligomers":[75,87],"organized":[76],"around":[77],"pathological":[78,105,152],"catalytic":[79,90],"trimers.":[80],"In":[81],"contrast,":[82],"gefitinib-sensitive":[83],"where":[88],"units":[91],"as":[93],"canonical":[94],"dimers,":[95],"those":[97],"found":[98],"in":[99,123],"wild-type":[100,169],"oligomers.":[101],"Genetically":[102],"disrupting":[103],"these":[104,151],"trimers":[106,132,154],"dimers":[108,130],"via":[109],"a":[110,140,160],"single-point":[111],"mutation":[112],"rewires":[113],"downstream":[114],"signaling,":[115],"decelerates":[116],"tumor":[117,135],"progression,":[118],"reverses":[120],"vivo":[124],".":[125],"Conversely,":[126],"genetic":[127],"engineering":[128],"reinstates":[133],"aggressive":[134],"growth.":[136],"These":[137],"findings":[138],"expose":[139],"vulnerability":[142],"unique":[143],"acquired":[145],"mutations,":[146],"demonstrating":[147],"selectively":[149],"targeting":[150],"intra-oligomer":[153],"can":[155],"overcome":[156],"provide":[159],"blueprint":[161],"for":[162],"protein-protein":[163],"interface":[164],"modulation":[165],"strategies":[166],"spare":[168],"signaling.":[170]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-09-26T00:00:00"}